BIOSITE INC 4

Accession 0001238913-07-000002

CIK 0000834306operating

View on SEC.gov Company Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 12:31 PM ET

Size

37.7 KB

Accession

0001238913-07-000002

Insider Transaction Report

Form 4

Period: 2007-06-29

BIOSITE INCBSTE

BLICKENSTAFF KIM D

Chairman & CEOOther

Transactions

Disposition from Tender
Common Stock
2007-06-29$92.50/sh−76$7,030→ 0 total
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−3,162→ 0 total
Exercise: $31.63Exp: 2010-06-02→ Common Stock (3,162 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−97,594→ 0 total
Exercise: $41.56Exp: 2011-06-14→ Common Stock (97,594 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−50,992→ 0 total
Exercise: $24.95Exp: 2012-06-18→ Common Stock (50,992 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−15,000→ 0 total
Exercise: $49.15Exp: 2014-10-22→ Common Stock (15,000 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,263→ 0 total
Exercise: $44.18Exp: 2014-06-18→ Common Stock (2,263 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−63,127→ 0 total
Exercise: $53.38Exp: 2015-06-17→ Common Stock (63,127 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−1,873→ 0 total
Exercise: $53.38Exp: 2015-06-17→ Common Stock (1,873 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−67,879→ 0 total
Exercise: $47.66Exp: 2013-06-18→ Common Stock (67,879 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,121→ 0 total
Exercise: $47.66Exp: 2013-06-18→ Common Stock (2,121 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−4,008→ 0 total
Exercise: $24.95Exp: 2012-06-18→ Common Stock (4,008 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,406→ 0 total
Exercise: $41.56Exp: 2011-06-14→ Common Stock (2,406 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−47,737→ 0 total
Exercise: $44.18Exp: 2014-06-18→ Common Stock (47,737 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−79,649→ 0 total
Exercise: $31.63Exp: 2010-06-02→ Common Stock (79,649 underlying)

Footnotes (13)

[F1]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $270,740 representing the difference between the exercise price of the option and $92.50, the merger consideration ($67.55 per share).
[F10]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $2,306,652 representing the difference between the exercise price of the option and $92.50, the merger consideration ($48.32 per share).
[F11]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $3,043,694 representing the difference between the exercise price of the option and $92.50, the merger consideration ($44.84 per share).
[F12]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $650,250 representing the difference between the exercise price of the option and $92.50, the merger consideration ($43.35 per share).
[F13]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $2,469,528 representing the difference between the exercise price of the option and $92.50, the merger consideration ($39.12 per share).
[F2]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $192,487 representing the difference between the exercise price of the option and $92.50, the merger consideration ($60.88 per share).
[F3]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $122,562 representing the difference between the exercise price of the option and $92.50, the merger consideration ($50.94 per share).
[F4]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $109,348 representing the difference between the exercise price of the option and $92.50, the merger consideration ($48.32 per share).
[F5]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $95,106 representing the difference between the exercise price of the option and $92.50, the merger consideration ($44.84 per share).
[F6]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $73,272 representing the difference between the exercise price of the option and $92.50, the merger consideration ($39.12 per share).
[F7]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $3,444,510 representing the difference between the exercise price of the option and $92.50, the merger consideration ($67.55 per share).
[F8]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $4,848,633 representing the difference between the exercise price of the option and $92.50, the merger consideration ($60.88 per share).
[F9]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $4,971,438 representing the difference between the exercise price of the option and $92.50, the merger consideration ($50.94 per share).

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOSITE INC

CIK 0000834306

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000834306

Filing Metadata

Form type: 4
Filed: Jul 1, 8:00 PM ET
Accepted: Jul 2, 12:31 PM ET
Size: 37.7 KB

View on SEC.gov